LUYE PHARMA GROUP LTD.

Estimates Revisions Luye Pharma Group Ltd.

Equities

2186

BMG570071099

Market Closed - Hong Kong S.E. Other stock markets 09:08:05 13/09/2024 BST			5-day change	1st Jan Change
2.950 ^HKD	+0.68%		-3.28%	-20.91%

08-30	Citi Upgrades Luye Pharma to Buy From Sell; Price Target is HK$4	MT
08-28	Luye Pharma Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

Turnover - Evolution of Analysts' Estimates

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

EBIT - Evolution of Analysts' Estimates

Dividend / Share (DPS) - Evolution of Analysts' Estimates

Cash or Net Debt - Evolution of Analysts' Estimates

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. EPS revision	1m. Revenue rev.	1y. EPS revision	1y. Revenue rev.
	LUYE PHARMA GROUP LTD.
	ELI LILLY AND COMPANY
	NOVO NORDISK A/S
	JOHNSON & JOHNSON
	ABBVIE INC.
	MERCK & CO., INC.
	ROCHE HOLDING AG
	ASTRAZENECA PLC
	NOVARTIS AG
	AMGEN INC.
	Average
	Weighted average by Cap.

See all sector revisions

Turnover

Estimates Revisions:

Earnings Per Share (EPS)

Estimates Revisions:

EBIT

Estimates Revisions:

Dividend / Share (DPS)

Estimates Revisions:

Cash or Net Debt

Estimates Revisions:

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW